A research group led by Assistant Professor Megumi Aimoto and Professor Akira Takahara at the Faculty of Pharmaceutical Sciences, Toho University, revealed that pyrazole-3 (Pyr3), a selective ...

A research group led by Assistant Professor Megumi Aimoto and Professor Akira Takahara at the Faculty of Pharmaceutical Sciences, Toho University, revealed that pyrazole-3 (Pyr3), a selective ...

Please provide your email address to receive an email when new articles are posted on . A novel SK ion channel inhibitor more often converted atrial fibrillation to sinus rhythm compared with placebo.

Acesion Pharma ApS has announced promising data from preclinical studies with AP-31969, its second-generation oral SK channel inhibitor developed for chronic oral maintenance treatment to prevent ...

Valvular atrial fibrillation (A-fib) involves a condition that leads to an irregular or abnormal heart rhythm. This can increase a person’s risk of cardiovascular complications, such as stroke.

A brand new procedure to treat atrial fibrillation is now being offered at several hospitals across Colorado after UCHealth in Loveland successfully completed the first procedure in the state. c "Afib ...